• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Red-Light Therapy Controls School-Age Myopia Progression in Six-Month Retrospective Study

by
November 10, 2026
in Health
Reading Time: 3 mins read
0
Red-Light Therapy Controls School-Age Myopia Progression in Six-Month Retrospective Study

Red-Light Therapy Controls School-Age Myopia Progression in Six-Month Retrospective Study

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Repeated low-level red-light therapy combined with single-vision spectacles effectively controlled myopia progression in school-age children over a six-month period, according to a clinical assessment published in BMC Ophthalmology. The retrospective, non-randomized investigation evaluated changes in ocular dimensions and refractive indicators among children aged 7 to 12 years receiving the intervention, alongside comparative spectacle modalities, reporting that the red-light protocol achieved treatment effects without any observed ocular adverse events.

The study cohort comprised a total of 101 pediatric patients diagnosed with myopia, divided into three specific clinical management groups. The primary treatment group received repeated low-level red-light therapy paired with single-vision spectacles, abbreviated as RLRL + SVS, and included 36 children. For comparative assessment, a second group of 38 participants was treated with highly aspherical lenslet target spectacles, known as HALT, while a third control cohort consisting of 27 children wore conventional single-vision spectacles alone.

To monitor ocular changes and comparative efficacy, the research team instituted distinct measurement schedules across the intervention arms. In the RLRL + SVS cohort, axial length was documented at baseline prior to treatment and subsequently reassessed at post-treatment intervals of one month, three months, and six months. Spherical equivalent refraction and subfoveal choroidal thickness were also evaluated in this red-light group before treatment and at the six-month mark. For both the HALT and single-vision spectacles groups, axial length measurements were recorded at baseline and at the concluding six-month evaluation.

Within the group receiving repeated red-light therapy with single-vision spectacles, axial length exhibited short-term reductions before stabilizing. Compared to pre-treatment baseline levels, axial length significantly decreased at one month and three months post-treatment, with statistical analyses indicating a value of P < 0.001 for both earlier intervals. By six months post-treatment, however, the observed axial length measurements in the RLRL + SVS group no longer differed significantly from baseline, yielding a value of P = 0.230.

The investigators also identified significant shifts in secondary ocular parameters within the RLRL + SVS group at the conclusion of the six-month study window. The participants’ spherical equivalent refraction changed from a baseline average of −2.40 ± 1.02 diopters to −2.27 ± 1.05 diopters at six months. Over the same timeframe, subfoveal choroidal thickness demonstrated a marked increase, expanding from 234.87 ± 40.57 micrometers prior to treatment to 253.86 ± 45.34 micrometers at six months, with both parameter modifications confirmed to be statistically significant.

Comparative analyses across all three cohorts demonstrated substantial divergence in axial elongation control over the six-month observation span. Mean axial length changes from baseline to six months were −0.03 ± 0.11 millimeters in the RLRL + SVS group, 0.02 ± 0.14 millimeters in the HALT group, and 0.22 ± 0.12 millimeters in the group wearing single-vision spectacles alone, representing a statistically significant overall variation (P < 0.001). Pairwise statistical comparisons revealed that axial elongation control in both the RLRL + SVS and HALT cohorts differed significantly from the single-vision spectacles group (P < 0.001), while no statistically significant difference was detected between RLRL + SVS and HALT (P = 0.270). The authors highlighted the non-randomized, retrospective nature of the study while noting that no ocular adverse events occurred during the trial.

Subject of Research: Repeated low-level red-light therapy for myopia progression in school-age children

Article Title: Impact of repeated low-level red-light therapy on myopia progression in the school-age population: a clinical assessment

Article References: Tang, F., Liang, Y., Chen, D., Du, Q., & Chen, J. (2026). Impact of repeated low-level red-light therapy on myopia progression in the school-age population: a clinical assessment. BMC Ophthalmology. https://doi.org/10.1186/s12886-026-05496-z

Image Credits: AI Generated

DOI: 10.1186/s12886-026-05496-z

Keywords: myopia, red-light therapy, axial length, ophthalmology, children, refractive error, choroidal thickness, spectacles, Impact, repeated, low-level, red-light

News Source: Ophelia Keating. (November 10, 2026). Red-Light Therapy Controls School-Age Myopia Progression in Six-Month Retrospective Study. Scienmag.

Tags: axial lengthchildrenchoroidal thicknessimpactlow-levelmyopiaOphthalmologyred-lightred-light therapyrefractive errorrepeatedspectacles
Share12Tweet7Share2ShareShareShare1

Related Posts

Home EEG Study Shows Gaboxadol Modulates Brain Oscillations in Fragile X Syndrome

Home EEG Study Shows Gaboxadol Modulates Brain Oscillations in Fragile X Syndrome

November 19, 2026
Incidental Abdominal Splenosis Resembling Metastatic Cancer Found During Elective Hernia Repair

Incidental Abdominal Splenosis Resembling Metastatic Cancer Found During Elective Hernia Repair

November 19, 2026

Single-Camera Video Predicts Knee Contact Forces but Lacks Clinical Accuracy

November 19, 2026

Rural South Africans Face Systemic Barriers in Managing Chronic Non-Communicable Diseases

November 19, 2026

POPULAR NEWS

  • Somatic Symptom Burden in Oral Health Clinic Patients Shifted Modestly Across Pandemic

    Somatic Symptom Burden in Oral Health Clinic Patients Shifted Modestly Across Pandemic

    29 shares
    Share 12 Tweet 7
  • Multicenter ICU Study Identifies Nurse Knowledge Gaps in Pneumonia Prevention

    29 shares
    Share 12 Tweet 7
  • Study Finds One-Third of Ethiopian Neuropsychiatric Patients Exhibit Harmful Alcohol Use

    29 shares
    Share 12 Tweet 7
  • Low-Dose Epidural Analgesia Modestly Lengthens Labor Stages in Low-Risk Women

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Home EEG Study Shows Gaboxadol Modulates Brain Oscillations in Fragile X Syndrome

Incidental Abdominal Splenosis Resembling Metastatic Cancer Found During Elective Hernia Repair

Review Identifies Molecular Networks Driving Colitis-Associated Colorectal Cancer and Emerging Therapies

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.